NIH Asthma Guide Concurs With FDA In Supporting LABAs For Adjunctive Use

Sales of combination inhaled corticosteroid/long-acting beta2-agonists may receive a boost from NIH guidelines endorsing their use as adjunctive therapy in certain asthma patients